VANCOUVER, British Columbia, Dec. 20, 2017 -- Upco International Inc. (CSE:UPCO) (Frankfurt:U06) (“Upco”) is pleased to announce that it has commenced development of its E-Wallet to support Cryptocurrencies such as Bitcoin and Ethereum using Blockchain Technology. With the development of the Upco E-Wallet using Cryptocurrencies, users will be able to: send invoices, approve payments, and track transfers and payments. The user will be able to choose his or her preferred method of payment using either common currencies (fiat) or Cryptocurrencies.
Mr Andrea Pagani, CEO and President commented: “The market cap and acceptance of Cryptocurrencies has increased tremendously in the last year. The market cap of Bitcoin has surpassed US$300 billion and Ethereum is over US$75 billion. We are developing our E-Wallet that will allow our users to have common currencies (fiat) and cryptocurrencies in it. Once developed, this will allow our users their choice of currency to use on our system.”
About Upco International Inc.
Upco International Inc. is a cloud-based mobile service company which provides high-quality voice termination to a market driven by the growing activity in online communications and commerce. Upco is a licensed Global Telecom Carrier within the international VoIP (voice over IP) wholesale business. Upco has designed a software application for Apple iOS and Android, similar to SKYPE and WhatsApp. With the forthcoming addition of the Upco E-Wallet using Blockchain Payment Services, users will be able to: send invoices, approve payments, transfer international funds, convert international currencies, and track transfers and payments. The application will also allow vendors to securely share account information with their clients.
Please visit www.upcointernational.com for further information.
ON BEHALF OF THE BOARD OF DIRECTORS
Jag Sandhu, Director and Vice President, Corporate Development
Neither the Canadian Securities Exchange nor its regulation services provider has reviewed or accepted responsibility for the adequacy or accuracy of the content of this news release.
Forward-Looking Statements
This press release contains forward-looking information or forward-looking statements (collectively "forward- looking information") within the meaning of applicable securities laws. Forward- looking information is typically identified by words such as: “will” “may” "believe", "expect", "anticipate", "intend", "estimate", “development”, “forthcoming”, "potentially" and similar expressions, or are those, which, by their nature, refer to future events. Upco cautions investors that any forward-looking information provided by Upco is not a guarantee of future results or performance, and that actual results may differ materially from those in forward-looking statements.


Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



